ClinicalTrials.Veeva

Menu

The Effects of Liquid IV's Multi-Ingredient Recovery Supplement on Muscle Recovery Following Exercise

Applied Science & Performance Institute logo

Applied Science & Performance Institute

Status

Not yet enrolling

Conditions

Physical Performance
Perceived Muscle Soreness
Muscle Damage
Perceived Recovery
Muscle Recovery
Strength Recovery

Treatments

Dietary Supplement: proprietary post workout recovery supplement
Dietary Supplement: Control placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT07224867
Pro00089373

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of a multi-ingredient recovery supplement . The research will focus on strength recovery and performance maintenance assessing reductions in soreness and inflammation, as well as muscle repair and damage mitigation. By investigating these key recovery metrics, this study aims to investigate the efficacy of this supplement as a solution for active individuals seeking to optimize post-exercise recovery.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy males or females aged 18-55 years old.
  • Must be recreationally trained or trained/developmental as previously defined (McKay et al., 2021).
  • Able to read and write in English.
  • Cessation of current use of tart cherry extract, protein powders, essential amino acids/BCAAs, collagen/collagen peptides, or anabolic agents for a minimum of 1-weeks prior to, and throughout the duration of the study.
  • Willing to maintain regular supplement routine otherwise during the trial, and will not introduce or discontinue a supplement, other than what was previously mentioned.
  • Will not participate in any strenuous exercise for a minimum of 1-week prior exercise performance assessments, as well as during the days of exercise testing. Strenuous exercise as defined for this study includes ½ and full marathons (or more), heavy (i.e.,>80% 1RM) lifting, and any high intensity, physical activity that could make your muscles sore.
  • During the study, you agree not to take any NSAIDs or other anti-inflammatory medications.

Exclusion criteria

  • Sedentary
  • Vegan, unwilling to consume animal bovine collagen
  • Highly trained/national level or professional athlete
  • Known diagnosis of any cardiovascular, metabolic, musculoskeletal, endocrine, or renal disease/disorder.
  • Recent musculoskeletal injury (<3-months)
  • Recent orthopaedic surgery (<12-months)
  • History or current malignancy.
  • Current respiratory infection (i.e., cold) or high temperature (fever) within the past 4-weeks.
  • Previous gastrointestinal surgery within the past 12 months.
  • Regular smoker.
  • Regular drinker (>14 drinks per week).
  • Those regularly using anti-inflammatory drugs within the last 4-weeks.
  • Current use of prescription medications that may influence adaptation to exercise (hormone therapies, peptides, etc.).
  • Allergies to study-related materials.
  • Any condition that impairs their ability to complete the required exercises.
  • Female subjects must not be pregnant or lactating.
  • Are unable to provide informed consent or are non-English speakers.
  • Presently using GLP-1 medications.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

30 participants in 2 patient groups, including a placebo group

proprietary post workout recovery supplement
Experimental group
Description:
Liquid I.V. post workout recovery powder mixture
Treatment:
Dietary Supplement: proprietary post workout recovery supplement
Control Treatment
Placebo Comparator group
Description:
inactive/inert placebo mixture
Treatment:
Dietary Supplement: Control placebo

Trial contacts and locations

1

Loading...

Central trial contact

Eric Sikorski, PhD; Gabe Wilson, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems